Gyrolab^® SpinBlog

03/20/2026

Advantages of Automated Immunoassays

03/17/2026

Automated detection of dsRNA contaminants in mRNA samples

01/13/2026

Choosing the Right Automated Immunoassay Platform for Your Analytical Needs

04/03/2025

Pre-existing anti-AAV immunity: a hidden barrier to gene therapy

07/17/2024

Overcoming Challenges in Electrochemiluminescence Assays (ECLA) During Pre-Clinical PK Studies with Microfluidic Technology

07/17/2024

How to Address ELISA Challenges in Preclinical PK Studies with Advanced Microfluidic Technology

07/17/2024

Advancing PK Studies: The Role of Microsampling in Monoclonal Antibody Therapeutics

04/06/2020

Enhancing the productivity of immunoassays: a 2-plex Gyrolab assay for both preclinical and clinical studies

02/27/2020

How to be confident in immunoassay determination of free versus bound target or drug

02/19/2020

Weighing up the advantages and disadvantages of multiplex assays

02/19/2020

Solutions to immunoassay interference, cross reactivity and other challenges

01/15/2020

Putting a new spin on immunoassays for cell and gene therapy – Part 2

01/15/2020

Putting a new spin on immunoassays for gene therapy – Part 1

07/24/2017

Ligand binding assays for regulated bioanalysis

05/15/2017

How to get it right the first time

01/26/2016

ADME of therapeutic proteins